Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

REPLIGEN CORPORATION

(RGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Insider Trends: 90-Day Insider Selling Trend Prolonged at Repligen

03/12/2021 | 07:37pm EDT


ę MT Newswires 2021
All news about REPLIGEN CORPORATION
05/05REPLIGENá : HC Wainwright Adjusts Repligen's Price Target to $240 From $225, Mai..
MT
05/04REPLIGENá : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/04REPLIGENá : Posts Rise in Q1 Adjusted Profit, Revenue; Amends 2021 Forecasts
MT
05/04REPLIGENá : Reported revenue was $142.8 million for the quarter, representing ye..
PU
05/04REPLIGEN CORPá : Results of Operations and Financial Condition, Financial Statem..
AQ
05/04REPLIGEN : Q1 Earnings Snapshot
AQ
05/04REPLIGENá : Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $142.8M,..
MT
05/04REPLIGENá : Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q1 EPS $0.68, vs...
MT
05/04Repligen Reports First Quarter 2021 Financial Resultsáand Updates Full Year 2..
GL
04/20Repligen to Report First Quarter 2021 Financial Results
GL
More news
Financials (USD)
Sales 2021 585 M - -
Net income 2021 97,5 M - -
Net cash 2021 596 M - -
P/E ratio 2021 101x
Yield 2021 -
Capitalization 9 422 M 9 422 M -
EV / Sales 2021 15,1x
EV / Sales 2022 12,6x
Nbr of Employees -
Free-Float 92,9%
Chart REPLIGEN CORPORATION
Duration : Period :
Repligen Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends REPLIGEN CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Average target price 240,25 $
Last Close Price 171,60 $
Spread / Highest target 46,3%
Spread / Average Target 40,0%
Spread / Lowest Target 16,6%
EPS Revisions
Managers and Directors
NameTitle
Tony J. Hunt President, Chief Executive Officer & Director
Jon K. Snodgres Chief Financial Officer
Karen T. Dawes Chairman
Ralf Kuriyel Senior Vice President-Research & Development
James R. Bylund Senior Vice President-Global Operations & IT
Sector and Competitors
1st jan.Capitalization (M$)
REPLIGEN CORPORATION-10.45%9 422
ABBOTT LABORATORIES8.13%206 733
MEDTRONIC PLC6.90%165 975
BECTON, DICKINSON AND COMPANY-3.43%70 273
ALIGN TECHNOLOGY, INC.2.67%43 417
HOYA CORPORATION-9.74%43 396